CRVS vs LKQ · $1.04B cap vs P/E 14, rev $6.88B
Corvus Pharmaceuticals Inc (CRVS) versus LKQ Corporation (LKQ) — a side-by-side from cached financials, not a winner call.
Corvus Pharmaceuticals Inc (CRVS) is a biotechnology company listed on US.
LKQ Corporation (LKQ) is a auto parts company listed on US.
CRVS does not have a complete income-statement cache yet.
Latest reported LKQ revenue for 2026-06-30 was $6.88B. Net income was $215.0M. Revenue was up 98.2% from 2026-03-31 to 2026-06-30. LKQ currently screens at market cap $9.99B and trailing P/E 14.4.
CRVS currently screens at market cap $1.04B. LKQ currently screens at market cap $9.99B and trailing P/E 14.4.
Not investment advice. Open the CRVS and LKQ stock pages for the full models.
Not investment advice.